| Sierrah Danielle Knorp, LPC | |
|
10350 E Dakota Ave, Denver, CO 80247-1314 | |
| (303) 338-4545 | |
| Not Available |
| Full Name | Sierrah Danielle Knorp |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 10350 E Dakota Ave, Denver, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073901534 | NPI | - | NPPES |
| 2846 | Other | MN | LAMFT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 2846 (Minnesota) | Secondary |
| 103TC0700X | Psychologist - Clinical | LPC.0013036 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sierrah Danielle Knorp, LPC 10350 E Dakota Ave, Denver, CO 80247-1314 Ph: (303) 338-4545 | Sierrah Danielle Knorp, LPC 10350 E Dakota Ave, Denver, CO 80247-1314 Ph: (303) 338-4545 |
News Archive
LifeVantage Corporation, has been granted a third patent for its flagship product Protandim from the United States Patent and Trademark Office. Protandim has been clinically proven in earlier studies to slow the progressive rate of aging by reducing oxidative stress and this new patent further documents Protandim's® effect on antioxidant enzymes in vivo, describing anti-inflammatory effects such as the lowering of C-reactive protein.
Pregnant women present during the September 11 World Trade Center collapse have passed on markers of Post Traumatic Stress Disorder (PTSD) to their unborn babies through transgenerational transmission. The findings strengthen the evidence for in utero or early life risk factors for the later development of adult mental or physical disorders.
MAP Pharmaceuticals, Inc. today announced that the Company will present nine analyses relating to its LEVADEX™ orally inhaled migraine therapy product candidate, including analysis from the FREEDOM-301 Phase 3 trial, at the 2010 European Headache and Migraine Trust International Congress (EHMTIC) in Nice, France.
Childhood obesity in the United States remains high. A tax on sugar-sweetened beverages such as sodas, energy drinks, sweet teas, and sports drinks would reduce obesity in adolescents more than other policies, such as exercise or an advertising ban, and would also generate significant revenue for additional obesity prevention activities, say researchers writing in the American Journal of Preventive Medicine.
Two types of guidance molecules, the attractive and the repulsive, direct the growth of nerve cells to the actual target. The designation of these molecules also describes the exclusive function that was previously attributed to them, namely to show the growing nerve fibers the way. The fundamentally new approach to the research of Prof. Dr. Schwab and his team at the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) is the realization that these guidance molecules have an additional hitherto unknown role in the immune system.
› Verified 7 days ago